Probability of Long-term Disease-free Survival (DFS) 1 year [clinicaltrials_resource:ec2e63858de37afb6cc48a9d40a448fa]
Number of participants with long-term disease free survival after being treated with busulfan (BU), cyclophosphamide (CY) and melphalan (L-PAM) followed by HCT for hematological malignancies.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Probability of Long-term Disease-free Survival (DFS) 1 year [clinicaltrials_resource:ec2e63858de37afb6cc48a9d40a448fa]
Number of participants with long-term disease free survival after being treated with busulfan (BU), cyclophosphamide (CY) and melphalan (L-PAM) followed by HCT for hematological malignancies.
Bio2RDF identifier
ec2e63858de37afb6cc48a9d40a448fa
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ec2e63858de37afb6cc48a9d40a448fa
measure [clinicaltrials_vocabulary:measure]
Probability of Long-term Disease-free Survival (DFS)
time frame [clinicaltrials_vocabulary:time-frame]
description
Number of participants with lo ...... or hematological malignancies.
identifier
clinicaltrials_resource:ec2e63858de37afb6cc48a9d40a448fa
title
Probability of Long-term Disease-free Survival (DFS) 1 year
@en
type
label
Probability of Long-term Disea ...... e63858de37afb6cc48a9d40a448fa]
@en